Klorhexidinsprit Fresenius Kabi (Chlorhexidine Gluconate)

Chlorhexidine gluconate acts by binding to bacterial cell membranes, disrupting their structure and causing leakage of intracellular contents. This loss of membrane integrity leads to rapid cell death, providing broad‑spectrum activity against Gram‑positive and Gram‑negative bacteria, some fungi, and certain viruses.

The appropriate amount of Klorhexidinsprit is determined by the prescribing healthcare professional based on the specific clinical situation, the area to be treated, and the product concentration. Dosing instructions are provided on the label or by the prescriber and should be followed exactly.

Safety data for chlorhexidine gluconate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and under medical supervision.

To order Klorhexidinsprit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Both chlorhexidine gluconate (Klorhexidinsprit) and povidone‑iodine are broad‑spectrum antiseptics, but chlorhexidine provides longer residual activity on the skin and is less irritating for many patients. Povidone‑iodine has a broader antiviral spectrum but may cause more staining and can be inactivated by organic material more readily.

Store Klorhexidinsprit at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme temperatures. Keep the product out of reach of children and avoid contamination of the applicator tip.

Klorhexidinsprit is applied topically to the skin. The prescribed amount is spread evenly over the intended area using a sterile swab or gauze, allowing it to dry before proceeding with any invasive procedure or dressing. Follow the prescriber’s instructions for contact time and any subsequent steps.

The most serious risks include rare but severe allergic reactions such as anaphylaxis and, in uncommon cases, severe chemical burns from prolonged exposure or high concentrations. Immediate medical attention is required if signs of systemic allergy, such as difficulty breathing, swelling, or widespread rash, occur.

Klorhexidinsprit should be avoided in individuals with a known hypersensitivity to chlorhexidine or any of its excipients. It is also not recommended for use on mucous membranes, the eyes, or on large broken skin areas unless specifically indicated by a healthcare professional.